**
In a significant shift in mental health treatment within the armed forces, the US military is poised to introduce MDMA-assisted therapy for active-duty soldiers grappling with post-traumatic stress disorder (PTSD). This initiative, backed by the Department of Defense (DoD), aims to provide soldiers with new coping strategies to address the psychological toll of combat experiences, marking a pivotal moment in the ongoing war against both PTSD and the stigma surrounding mental health treatments in the military.
A New Approach to Combat Trauma
The forthcoming studies, which are expected to commence in 2024, will involve 186 service members suffering from PTSD participating in multiple sessions of MDMA-assisted therapy. This innovative approach is being closely monitored by Sean O’Keefe, the deputy under secretary of defence for personnel and readiness, as the military prepares to train a cadre of therapists skilled in psychedelic-assisted therapy.
Rick Doblin, the founding president of the Multidisciplinary Association for Psychedelic Studies (MAPS), has been a vocal advocate for the therapeutic potential of MDMA. He asserts that assisting individuals in processing trauma is not only beneficial but essential. “Helping people process trauma, whoever they are, is probably better than not,” he stated, reinforcing the moral imperative behind this new treatment paradigm.
Legislative Backing for Psychedelic Research
The funding for this groundbreaking research was approved as part of the National Defence Authorization Act in December 2023, a legislative move championed by former President Joe Biden. This act, which included provisions from Republican Congressman Morgan Luttrell, underscores the bipartisan support for exploring new avenues of treatment for veterans and active-duty personnel alike. Luttrell, a veteran Navy Seal with personal experience in psychedelic therapy, emphasised that “our men and women in uniform deserve every tool available to heal and stay in the fight.”
The urgency of addressing the mental health crisis within the military is further highlighted by the alarming suicide rates among veterans. In an Oval Office signing ceremony, Donald Trump remarked on the “national tragedy” of veteran suicides, noting that the toll has exceeded battlefield casualties since the events of September 11.
Concerns of Ethical Use in Combat Settings
While the potential benefits of MDMA therapy are promising, experts caution against its use as a means to enhance combat readiness. Dennis McKenna, an ethnobotanist, expressed concern about the ethical implications of restoring soldiers to health only to return them to the battlefield. “It would be completely cynical and cruel of the government to throw them back into combat,” he stated, warning of the dangers of utilising psychedelics to merely create more effective combatants.
Doblin echoed these sentiments, noting the risk of relapse into PTSD symptoms when soldiers are re-exposed to stressful environments. The balance between healing and utilising therapies to bolster military effectiveness raises significant ethical questions that require careful consideration.
Global Perspectives on Psychedelic Therapy
The interest in psychedelic therapy is not confined to the United States. In Ukraine, where the military grapples with untreated PTSD among its ranks, MAPS has trained therapists to facilitate MDMA-assisted sessions for soldiers. Although legal access to MDMA remains limited, many troops have already benefited from therapies involving ketamine, a dissociative anaesthetic that has shown efficacy in treating PTSD symptoms.
Internationally, Israel is set to launch a significant MDMA-assisted therapy study for victims of the recent Hamas attacks, involving both military veterans and active soldiers. Psychologist Keren Tzarfaty, who is leading the research, aims to create a model for addressing collective trauma that could resonate globally.
A Paradigm Shift in Mental Health Treatment
As the military prepares to embrace psychedelic therapies, the implications extend far beyond the immediate treatment of PTSD. The two upcoming studies will be the first of their kind to formally examine the effects of psychedelics on soldiers, a stark contrast to historical practices involving drugs like LSD used in the mid-20th century.
The prospect of integrating emotional training into military programmes, such as MDMA sessions during boot camp, suggests a forward-thinking approach to mental health that could reshape how the armed forces prepare their personnel for the emotional challenges of combat.
Why it Matters
The introduction of MDMA-assisted therapy for active-duty soldiers represents a landmark shift in addressing the mental health crisis within the military. By potentially offering effective treatment for PTSD, this initiative not only aims to enhance the well-being of service members but also challenges longstanding stigmas surrounding mental health in the armed forces. As the military grapples with the consequences of combat on mental health, this approach could pave the way for a more compassionate and effective framework for supporting those who serve. The implications are profound—not just for soldiers, but for society at large, as we begin to rethink our understanding of trauma and healing in the context of warfare.